172 related articles for article (PubMed ID: 1828426)
1. Stimulation of B lymphocytes via CD72 (human Lyb-2).
Kamal M; Katira A; Gordon J
Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426
[TBL] [Abstract][Full Text] [Related]
2. Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes.
Katira A; Kamal M; Gordon J
Immunology; 1992 Jul; 76(3):422-6. PubMed ID: 1388135
[TBL] [Abstract][Full Text] [Related]
3. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
4. Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40.
Gordon J; Millsum MJ; Flores-Romo L; Gillis S
Immunology; 1989 Dec; 68(4):526-31. PubMed ID: 2481643
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40.
Gordon J; Katira A; Strain AJ; Gillis S
Eur J Immunol; 1991 Aug; 21(8):1917-22. PubMed ID: 1714394
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.
Gascan H; Gauchat JF; Aversa G; Van Vlasselaer P; de Vries JE
J Immunol; 1991 Jul; 147(1):8-13. PubMed ID: 1711085
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling.
Gordon J; Cairns JA; Millsum MJ; Gillis S; Guy GR
Eur J Immunol; 1988 Oct; 18(10):1561-5. PubMed ID: 2847932
[TBL] [Abstract][Full Text] [Related]
8. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production.
Zhang K; Clark EA; Saxon A
J Immunol; 1991 Mar; 146(6):1836-42. PubMed ID: 1706382
[TBL] [Abstract][Full Text] [Related]
9. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand.
Bishop GA; Warren WD; Berton MT
Eur J Immunol; 1995 May; 25(5):1230-8. PubMed ID: 7539751
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4.
Rigley KP; Callard RE
Eur J Immunol; 1991 Mar; 21(3):535-40. PubMed ID: 1707000
[TBL] [Abstract][Full Text] [Related]
11. A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels.
Santos-Argumedo L; Teixeira C; Preece G; Kirkham PA; Parkhouse RM
J Immunol; 1993 Sep; 151(6):3119-30. PubMed ID: 8397252
[TBL] [Abstract][Full Text] [Related]
12. IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway.
Taieb J; Leca G; Auffredou MT; Galanaud P; Vazquez A
Eur Cytokine Netw; 1991; 2(4):265-72. PubMed ID: 1721849
[TBL] [Abstract][Full Text] [Related]
13. Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation.
Zamorano J; Rivas D; Gayo A; Mozo L; Gutiérrez C
Immunology; 1995 Jun; 85(2):241-7. PubMed ID: 7642212
[TBL] [Abstract][Full Text] [Related]
14. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor.
Wheeler K; Pound JD; Gordon J; Jefferis R
Eur J Immunol; 1993 May; 23(5):1165-8. PubMed ID: 7682959
[TBL] [Abstract][Full Text] [Related]
15. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
Luo HY; Hofstetter H; Banchereau J; Delespesse G
J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
[TBL] [Abstract][Full Text] [Related]
16. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4.
Dugas B; Paul-Eugene N; Cairns J; Gordon J; Calenda A; Mencia-Huerta JM; Braquet P
J Immunol; 1990 Nov; 145(10):3406-11. PubMed ID: 2172383
[TBL] [Abstract][Full Text] [Related]
18. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
19. CD72 ligation regulates defective naive newborn B cell responses.
Howard LM; Reen DJ
Cell Immunol; 1997 Feb; 175(2):179-88. PubMed ID: 9023424
[TBL] [Abstract][Full Text] [Related]
20. Soluble forms of CD40 inhibit biologic responses of human B cells.
Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ
J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
